What is the lipitor loyalty program?

What is the Lipitor loyalty program?
Pfizer ran a Lipitor loyalty program in the late 1990s and early 2000s to keep patients on the branded statin once generic versions became available. The program offered coupons, co-pay cards, and mail-order discounts that reduced the cost of brand-name Lipitor to levels competitive with generics.

Who ran the program and why was it created?
Pfizer launched the program ahead of Lipitor’s U.S. patent expiry in November 2011. The goal was to slow the shift to lower-priced atorvastatin generics by making the brand-name product financially attractive to insured and uninsured patients alike.

How did the discounts actually work?
Patients enrolled online or through their doctor and received a savings card that capped out-of-pocket costs at around $15–$30 per fill for up to 12 months. Some versions also included free trial offers or automatic-refill discounts for mail-order pharmacy users.

Did the program affect generic uptake?
The loyalty cards temporarily kept a measurable share of prescriptions on the brand, but most patients and payers eventually switched once the generic price dropped below the co-pay savings offered by Pfizer.

When did the program end?
Pfizer phased out the Lipitor loyalty cards shortly after multiple generic manufacturers entered the market in late 2011 and early 2012, once the brand’s pricing advantage disappeared.

Are there similar programs for atorvastatin today?
Current manufacturer-sponsored savings cards for brand-name Lipitor no longer exist. Generic atorvastatin is widely available at low fixed prices through discount programs such as GoodRx or pharmacy loyalty clubs, and most insurance plans cover the generic with minimal copay.